Sign up for our upcoming events >>
Home
About
Learn
Advocate
Connect
Resources
More
Alpha PRRT with Pb-212 (all NET)
Alpha PRRT with Ac-225 (GEP-NETs only)
Lu-177 DOTATATE + M3814 (Peposertib)Â (GEP-NETs)
Lu-177 DOTATATE + Olaparib (GEP-NETs)
Lu-177 DOTATATE + Triapine (GEP-NETs)
Lu-177 DOTATATE + Cabozantanib (all NET)
COMPOSE (GEP-NETS)
NETTER-P: Lutathera in Adolescent PatientsÂ
NET RETREAT of Lu-177 Retreatment vs Everolimus in Midgut NET
CABINET: Cabozantinib in Advanced pNET and Carcinoid Tumors
CDK4/6 Abemaciclib
Â
Paltusotine in Carcinoid SyndromeÂ
SORENTOâ„¢: Subcutaneous Octreotide for GEP-NETs
Survivin Long Peptide Vaccine (SurVaxM) in Metastatic NETs
Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs)